Market Research Logo

China Pharmaceuticals and Healthcare Report Q2 2016

China Pharmaceuticals and Healthcare Report Q2 2016

BMI View: The merger of China's new rural cooperative medical scheme with its urban residents basicmedical insurance scheme will reshape the country's healthcare landscape. This will have importantramifications for the pharmaceutical industry as reimbursement models shift correspondingly. While thisperpetuates the shifting dynamics within China in 2016, the long-term impacts are positive - expanding thedepth of coverage to more patients and improving the system's financial sustainability.

Headline Expenditure Projections

Pharmaceuticals: CNY687bn (USD107bn) in 2015 to CNY770bn (USD115bn) by 2016; +12% in localcurrency terms and +7.1% in USD terms.

Healthcare: CNY4,078bn (USD639bn) in 2015 to CNY4,628bn (USD693bn) in 2015; +13.5% in localcurrency and +9.6% in USD terms.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (China 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (China 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (China 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (China 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (China 2012-2020)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (China 2012-2020)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (China 2012-2020)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (China 2012-2020)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (China 2012-2020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (China 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (China 2014-2020)
Industry Risk/Reward Index
Asia Pacific Risk/Reward Index
China Risk/Reward Index
Rewards
Risks
Regulatory Review
Regulatory Regime
Table: Important China GMP Deadlines
Intellectual Property Issues
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (China 2010-2015)
Table: Healthcare Personnel (China 2010-2015)
Table: Healthcare Activity (China 2010-2015)
Research & Development
Table: Selected List Of MNC With R&D Bases In China
Table: Selected List Of Collaboration In R&D Operations In China
Clinical Trials
Epidemiology
Table: Estimated Number Of New Cases Of Cancer In China
Competitive Landscape
Research-Based Industry
Table: Companies Represented by RDPAC
Table: Multinational Market Activity
Generic Drugmakers
Table: Top 20 China/Hong Kong-Based Pharmaceutical Companies According To Market Capitalisation
Pharmaceutical Distribution
Company Profile
AstraZeneca
Bayer
China Shijiazhuang Pharmaceutical Group
Eli Lilly
GlaxoSmithKline
North China Pharmaceutical Corporation
Novartis
Merck & Co
Merck KGaA
Pfizer
Roche
Sanofi
Shanghai Pharmaceutical
Sinopharm
Demographic Forecast
Table: Population Headline Indicators (China 1990-2025)
Table: Key Population Ratios (China 1990-2025)
Table: Urban/Rural Population & Life Expectancy (China 1990-2025)
Table: Population By Age Group (China 1990-2025)
Table: Population By Age Group % (China 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report